# AVADEL PHARMACEUTICALS PLC

AVADEL PHARMACEUTICALS PLC is a company headquartered in Dublin 2, Ireland.

## Company overview

- **Legal name:** AVADEL PHARMACEUTICALS PLC
- **Former names in filing history:** FLAMEL TECHNOLOGIES SA (1997-02-25 to 2016-12-30)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Dublin 2, Ireland
- **Fiscal year end:** December 31
- **SEC CIK:** 0001012477

## About

AVADEL PHARMACEUTICALS PLC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001012477, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-03, it reported annual revenue of USD 169,117,000; net income of USD -48,832,000; total assets of USD 164,236,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $169.1M (USD 169,117,000)
- **Net income:** -$48.8M (USD -48,832,000)
- **Total assets:** $164.2M (USD 164,236,000)
- **Cash and equivalents:** $51.4M (USD 51,371,000)
- **Operating cash flow:** -$46.9M (USD -46,907,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $28.0M (USD 27,963,000)
- **Net income:** -$160.3M (USD -160,276,000)
- **Total assets:** $164.7M (USD 164,698,000)
- **Cash and equivalents:** $31.2M (USD 31,167,000)
- **Operating cash flow:** -$128.5M (USD -128,511,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$137.5M (USD -137,464,000)
- **Total assets:** $132.8M (USD 132,785,000)
- **Cash and equivalents:** $74.0M (USD 73,981,000)
- **Operating cash flow:** -$70.3M (USD -70,304,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$77.3M (USD -77,329,000)
- **Total assets:** $247.3M (USD 247,265,000)
- **Cash and equivalents:** $50.7M (USD 50,708,000)
- **Operating cash flow:** -$77.3M (USD -77,310,000)

## Recent SEC filings

- Form 8-K — filed 2026-02-12 — period 2026-02-12 — FORM 8-K
- Form 8-K — filed 2026-01-20 — period 2026-01-19 — FORM 8-K
- Form 8-K — filed 2026-01-12 — period 2026-01-12 — FORM 8-K
- Form 8-K — filed 2025-12-18 — period 2025-12-18 — FORM 8-K
- Form 8-K — filed 2025-12-09 — period 2025-12-08 — FORM 8-K
- Form 8-K — filed 2025-11-19 — period 2025-11-18 — FORM 8-K
- Form 8-K — filed 2025-11-17 — period 2025-11-17 — FORM 8-K
- Form 8-K — filed 2025-11-14 — period 2025-11-14 — FORM 8-K
- Form 10-Q — filed 2025-11-04 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-04 — period 2025-11-04 — FORM 8-K
- Form 8-K — filed 2025-10-22 — period 2025-10-22 — FORM 8-K
- Form 8-K — filed 2025-10-22 — period 2025-10-21 — FORM 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/avadel-pharmaceuticals-plc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology